Investigating the effects of high-dose phenylephrine in the management of prolonged ischaemic priapism

Journal of Sexual Medicine

Volumn 5, Issue 9, 2008, Pages 2152-2159

  Muneer, Asif ^a,b   Minhas, Suks ^a   Freeman, Alex ^c   Kumar, Pardeep ^a   Ralph, David J ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Corpus Cavernosum; Erectile Dysfunction; Penis; Phenylephrine; Priapism; Smooth Muscle

Indexed keywords

PHENYLEPHRINE;

ACIDOSIS; ADULT; APOPTOSIS; ARTICLE; BLOOD GAS ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DISEASE DURATION; DOPPLER ECHOGRAPHY; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESPONSE; DRUG TREATMENT FAILURE; HUMAN; HUMAN TISSUE; HYPOXIA; IN VITRO STUDY; MALE; NICK END LABELING; PENIS AMPUTATION; PENIS CANCER; PENIS ERECTION; PRIAPISM; PRIORITY JOURNAL; REPEATED DRUG DOSE; SMOOTH MUSCLE CONTRACTION; UNSPECIFIED SIDE EFFECT;

EID: 51349100463     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.00862.x     Document Type: Article

References (19)

1. Rees RW, Kalsi J, Minhas S, Peters J, Kell P, Ralph DJ. The management of low-flow priapism with the immediate insertion of a penile prosthesis. BJU Int 2002;90:893-7.
2. Pryor J, Akkus E, Alter G, Jordan G, Lebret T, Levine L, Mulhall J, Perovic S, Ralph D, Stackl W. Priapism. J Sex Med 2004;1:116-20.
3. Martinez PF, Hoang-Boehm J, Weiss J, Alken P, Junemann K. Methylene blue as a successful treatment alternative for pharmacologically induced priapism. Eur Urol 2001;39:20-3.
4. Shantha TR, Finnerty DP, Rodriquez AP. Treatment of persistent penile erection and priapism using terbutaline. J Urol 1989;141:1427-9.
5. Glina S, Burnett AL, Becher E, Brock G, Hellstrom W. Priapism: Reasons for failure by Frank Hinman Jr. J Sex Med 2007;4:1539-43.
6. Lue TF, Pescatori ES. Distal cavernosum-glans shunts for ischemic priapism. J Sex Med 2006;3:749-52.
7. Broderick GA, Gordon D, Hypolite J, Levin RM. Anoxia and corporal smooth muscle dysfunction: A model for ischemic priapism. J Urol 1994;151:259-62.
8. Saenz de Tejada I, Kim NN, Daley JT, Royai R, Hypolite J, Broderick GA, Garcia-Diaz F, Levin R. Acidosis impairs rabbit trabecular smooth muscle contractility. J Urol 1997;157:722-6.
9. Muneer A, Cellek S, Dogan A, Kell PD, Ralph DJ, Minhas S. Investigation of cavernosal smooth muscle dysfunction in low flow priapism using an in vitro model. Int J Impot Res 2005;17:10-8.
10. Moon DG, Lee DS, Kim JJ. Altered contractile response of penis under hypoxia with metabolic acidosis. Int J Impot Res 1999;11:265-71.
11. Munarriz R, Wen CC, McAuley I, Goldstein I, Traish A, Kim N. Management of ischemic priapism with high-dose intracavernosal phenylephrine: From bench to bedside. J Sex Med 2006;3:918-22.
12. Cellek S, Moncada S. Nitrergic control of peripheral sympathetic responses in the human corpus cavernosum: A comparison with other species. Proc Natl Acad Sci USA 1997;94:8226-31.
13. Rees DD, Cellek S, Palmer RM, Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock. Biochem Biophys Res Commun 1990;173:541-7.
14. Broderick GA, Harkaway R. Pharmacologic erection: Time-dependent changes in the corporal environment. Int J Impot Res 1994;6:9-16.
15. Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. J Urol 1986;135:142-7.
16. Kulmala RV, Tamella TL. Effects of priapism lasting 24 hours or longer caused by intracavernosal injection of vasoactive drugs. Int J Impot Res 1995;7:131-6.
17. Pessina F, McMurray G, Wiggin A, Brading AF. The effect of anoxia and glucose-free solutions on the contractile response of guinea-pig detrusor strips to intrinsic nerve stimulation and the application of excitatory agonists. J Urol 1997;157:2375-80.
18. Burnett AL, Bivalacqua TJ, Champion HC, Musicki B. Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. J Sex Med 2006;3:1077-84.
19. Rajfer J, Gore JL, Kaufman J, Gonzalez-Cadavid N. Case report: Avoidance of palpable corporal fibrosis due to priapism with upregulators of nitric oxide. J Sex Med 2006;3:173-6.